Clinical Trial Update: Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase I/II study of vorinostat with paclitaxel and bevacizumab in metastatic breast cancer; the trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Stage IIIB Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-11-05